Gilead (GILD) plans to move forward with the sale of generic versions of four HIV treatments in...

|About: Gilead Sciences, Inc. (GILD)|By:, SA News Editor

Gilead (GILD) plans to move forward with the sale of generic versions of four HIV treatments in developing countries under the terms of an agreement with a UN-backed patent foundation. New studies show the firm's Truvada HIV pill can prevent the virus transmission, after an early study said the opposite.